ArticleCancer cell international2016

Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways.

Mohammadreza Zamanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.